Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2019/06/019823
CTRI/2019/06/019823Not yet recruitingPhase 1/2

Comparative Clinical trial of efficacy of Haridrakahanda and Vyoshadi vati in the management of Allergic Rhinitis as prophyalctic medicine

Tilak Ayurved Mahavidyalaya1 site in 1 country30 target enrollmentStarted: June 24, 2019Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 1/2
Status
Not yet recruiting
Enrollment
30
Locations
1
Primary Endpoint
To study the efficacy of Haridrakahanda and Vyoshadi vati in the management of Allergic Rhinitis as prophyalctic medicine
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Allergic rhinitis is one of the most commonest disease found due to this changes.allergic rhinitis is well known for its recurrence.Recurrence of disease occur only when vitiated doshas have not been  eradicated completely. In allergic rhinitis principle of treatment is avoid allergens causing allergic reaction, detoxification, and prophylactic treatment to increase the immunity and to decrease Recurrence of disease. Haridrakhanada has anti allergic and antioxidant property.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
Open Label

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Patient diagnosed as alleegic rhinitis.

Exclusion Criteria

  • •Patients with vasomotor rhinitis, acute infective rhinitis, atrophic rhinitis, pregnant women, lactating mother, patients suffering from malignancy, tuberculosis, systemic illness.

Outcomes

Primary Outcomes

To study the efficacy of Haridrakahanda and Vyoshadi vati in the management of Allergic Rhinitis as prophyalctic medicine

Time Frame: 3 months

Secondary Outcomes

  • To study efficacy of Haridrakahanda in management of allergic rhinitis as prophylactic medicine(To study the efficacy of vyoshadi vati in management of allergic rhinitis as prophylactic medicine)

Investigators

Sponsor Class
Research institution and hospital

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Phase 3
Role Of Jala Neti And Pratimarsha Nasya In The Management Of Vataj Pratishaya (Allergic Rhinitis )
CTRI/2022/02/040468Dr Hemant kumar120
Not yet recruiting
Phase 2
Effect of chaturajata taila inhaler in allergic rhinitis
CTRI/2023/06/054256Dean Parul institute of ayurved100
Completed
Phase 2
Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis AdultSeasonal Allergic Rhinitis
NCT06046391Longbio Pharma180
Not yet recruiting
Not Applicable
Study of effectiveness of Vyoshadi Vati given with and without Surasasidhha taila nasya for 21 days in Allergic rhinitis patients.
CTRI/2020/04/024478Principal PDEAs college of ayurved and research centre60
Completed
Not Applicable
Study of the effect of Shigru Taila Nasya,Gaganesvara Rasa and Haritakyadi Churna Virechana in Allergic Rhinitis.
CTRI/2022/07/043987National institute Of Ayurveda Deemed To Be University Jaipur30